Site Search
Medicaid Program Changes: Addressing Concerns for the Clinical Laboratory
The Patient Protections and Affordable Care Act (PPACA) activates and increases the funding for the Medicaid Integrity Program (MIP) passed as part of the Deficit Reduction Act (DRA) of 2005. This legislation created a program designed to focus government resources on preventing fraud and abuse in the Medicaid and Children's Health Insurance Program (CHIP) by implementing a specific plan and strategy to accomplish that goal. This session will address the need for clinical laboratories to prepare for this new focus by explaining the changes coming to these programs and how labs can best protect themselves.
Originally presented September 28, 2010.
Lecture Presenter
Christopher P. Young, CHC
President, Laboratory Management Support Services
Certified in health care compliance, Chris Young is a compliance professional with 20 years of experience in laboratory compliance and over 40 years working in clinical laboratories. He serves as the laboratory representative on the Medicare Carrier Advisory Committee for Arizona and is CLMA's representative on the Pathology Coding Caucus. Mr. Young speaks and writes locally and nationally on health care and laboratory compliance issues, Medicare/Medicaid billing, and other laboratory topics. He is an independent consultant specializing in regulatory matters and developing compliance officers and programs for clinical laboratories.
Objectives
After this presentation, attendees will be able to:
- Explain the fraud and abuse provisions contained in PPACA that pertain to the Medicaid and CHIP programs.
- Understand what the Medicaid Integrity Program is and how it will affect laboratories and other providers.
- Formulate a plan to monitor and prepare for these changes.
Sponsored by:
University of Utah School of Medicine and ARUP Laboratories